820 related articles for article (PubMed ID: 33535239)
1. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
Sharma D
Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
[TBL] [Abstract][Full Text] [Related]
3. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
Front Immunol; 2021; 12():632478. PubMed ID: 33763077
[TBL] [Abstract][Full Text] [Related]
4. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
[No Abstract] [Full Text] [Related]
6. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.
de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC
Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274
[TBL] [Abstract][Full Text] [Related]
7. Convergence between global BCG vaccination and COVID-19 pandemic.
Islam MZ; Zahan MK; Al-Bari MAA
J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
[TBL] [Abstract][Full Text] [Related]
8. Immunology Lessons from the SARS-CoV-2 Pandemic.
Yokoyama WM; Hogquist KA; O'Shea JJ
Annu Rev Immunol; 2021 Apr; 39():v-vii. PubMed ID: 33939926
[No Abstract] [Full Text] [Related]
9. Vaccine-induced protection in aging adults and pandemic response.
Schenkelberg T
Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845
[No Abstract] [Full Text] [Related]
10. Could mixing COVID vaccines boost immune response?
Ledford H
Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
[No Abstract] [Full Text] [Related]
11. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
Jin P; Li J; Pan H; Wu Y; Zhu F
Signal Transduct Target Ther; 2021 Feb; 6(1):48. PubMed ID: 33531462
[TBL] [Abstract][Full Text] [Related]
12. Why Oxford's positive COVID vaccine results are puzzling scientists.
Callaway E
Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
[No Abstract] [Full Text] [Related]
13. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
Russell RL; Pelka P; Mark BL
Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
[TBL] [Abstract][Full Text] [Related]
14. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
15. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.
Motamedi H; Ari MM; Dashtbin S; Fathollahi M; Hossainpour H; Alvandi A; Moradi J; Abiri R
Int Immunopharmacol; 2021 Jul; 96():107763. PubMed ID: 34162141
[TBL] [Abstract][Full Text] [Related]
16. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
Vashishtha VM
Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
[TBL] [Abstract][Full Text] [Related]
17. UK science advisers: publish evidence behind COVID vaccine changes.
Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 vaccine candidates in rapid development.
Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
[TBL] [Abstract][Full Text] [Related]
19. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
20. Africa's need for more COVID-19 clinical trials.
Makoni M
Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
[No Abstract] [Full Text] [Related]
[Next] [New Search]